Inventor · disambiguated record
Primali Vasundera Navaratne
Also filed as: NAVARATNE PRIMALI · NAVARATNE PRIMALI VASUNDERA
0 granted patents·10 pending applications·0 citations·filing 2021–2025
Files withAMGEN INC10
Top patents by PatentIndex Score
10 records- 0176US2025304599A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2024·Application pending·0 cites
- 0269US2025236631A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 0358US2025179077A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 0455US2025034167A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 0555US2025122222A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 0654US2024124442A1Tricyclic-amido-bicyclic prmt5 inhibitorsAMGEN INC·Filed 2022·Application pending·0 cites
- 0754US2025059179A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 0854US2024417412A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 0954US2025059205A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 1052US2024101570A1Tricyclic carboxamide derivatives as prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Primali Vasundera Navaratne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →